| 1 | Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma | npj Precision Oncology | Natalie Y.L. Ngoi, Ian M. Silverman et al. | 1 |
| 2 | IAM1363-01: A phase 1/1b study of a selective and brain-penetrant HER2 inhibitor for HER2-driven solid tumors. | Journal of Clinical Oncology | Alex A. Adjei, Kwok‐Kin Wong et al. | 3 |
| 3 | Ataxia telangiectasia and Rad3-related (ATR) inhibitor camonsertib dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study) | JNCI Journal of the National Cancer Institute | Elisa Fontana, Ezra Y. Rosen et al. | 7 |
| 4 | Development of a Practical Nomogram for Personalized Anemia Management in Patients Treated with Ataxia Telangiectasia and Rad3-related Inhibitor Camonsertib | Clinical Cancer Research | Ezra Y. Rosen, Timothy A. Yap et al. | 4 |
| 5 | PALLAS: PALbociclib CoLlaborative adjuvant study: A randomized phase 3 trial of palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for HR+/HER2- early breast cancer | Annals of Oncology | Erica L. Mayer, Angela DeMichele et al. | 7 |
| 6 | Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial breakdown → | The Lancet Oncology | Massimo Cristofanilli, Nicholas C. Turner et al. | 1247 |
| 7 | Phase III study of Palbociclib in combination with Exemestane vs. Capecitabine, in Hormonal Receptor (HR) positive/HER2 negative Metastatic Breast Cancer (MBC) patients with Resistance to non-steroidal Aromatase inhibitors (NSAI): PEARL study (GEICAM/2013-02_CECOG/BC.1.3.006) | Journal of Clinical Oncology | Miguel Martín, Moshe Inbar et al. | 1 |
| 8 | Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting | Chinese Journal of Cancer | Roger Luo, Jian Ding et al. | 2 |
| 9 | Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer breakdown → | Journal of Clinical Oncology | Kimberly Blackwell, Harold J. Burstein et al. | 701 |
| 10 | Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2–Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor | Clinical Cancer Research | Maurizio Scaltriti, Sarat Chandarlapaty et al. | 114 |
| 11 | Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast Cancer | Journal of Clinical Oncology | Richard S. Finn, Michael F. Press et al. | 144 |
| 12 | Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast Cancer | Journal of Clinical Oncology | Angelo Di Leo, Henry Gómez et al. | 345 |
| 13 | HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer | Clinical Cancer Research | Michael F. Press, Richard S. Finn et al. | 134 |
| 14 | Rhabdomyolysis in allogeneic peripheral blood stem cell donors | Vox Sanguinis | Julie Schanz, Claudia Wolf et al. | 4 |
| 15 | Diminished Antibody Response to Hepatitis B Immunization in Children With Sickle Cell Disease | Journal of Pediatric Hematology/Oncology | Jeffrey D. Hord, María Koehler et al. | 13 |
| 16 | The Use of Counterflow Centrifugal Elutriation for the Depletion of T Cells from Unrelated Donor Bone Marrow | Journal of Hematotherapy | Steven Neudorf, Witold B. Rybka et al. | 4 |
| 17 | Complications of Bacteremia Due to Stomatococcus mucilaginosus in Neutropenic Children | Clinical Infectious Diseases | Scott Henwick, María Koehler et al. | 26 |
| 18 | Childhood Acute Lymphoblastic Leukemia Immunophenotypes and their Prognostic Significance: Experience of the IGCI-Study in 389 Children | Leukemia & lymphoma | Jerzy Hołowiecki, María Koehler et al. | 2 |
| 19 | The effects of long term methotrexate therapy on the gonadal function and morphology. | PubMed | María Koehler et al. | 1 |
| 20 | Effects of Methotrexate on Rabbit Testes Part 2: Hormonal Changes | Pediatric Hematology and Oncology | María Koehler, U. Heinrich et al. | 11 |